Related Experiment Video

Updated: Jun 15, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

212

Consensus on glycemic management for patients with coronary heart disease and type 2 diabetes

, Li-Nong Ji, Yun-Dai Chen

    Journal of Geriatric Cardiology : JGC
    |August 26, 2024
    PubMed

    Insights

    Patients with coronary heart disease and type 2 diabetes face high cardiovascular risks. This consensus standardizes glycemic management using novel glucose-lowering medications like GLP-1 RAs and SGLT-2i to reduce these risks.

    Area of Science:

    • Cardiology
    • Endocrinology
    • Pharmacology

    Background:

    • High prevalence of coronary heart disease (CHD) and diabetes mellitus leads to significant residual cardiovascular risks.
    • Existing interventions do not fully mitigate cardiovascular risks in diabetic CHD patients.
    • Cardiologists show gaps in knowledge regarding type 2 diabetes screening and underutilize glucose-lowering medications with proven cardiovascular benefits, such as GLP-1 RAs and SGLT-2i.

    Purpose of the Study:

    • To standardize glycemic management for patients with CHD, including those with acute coronary syndrome, chronic coronary syndrome, and undergoing percutaneous coronary intervention.
    • To provide guidance on screening, diagnosis, and comprehensive cardiovascular risk management for type 2 diabetes in CHD patients.
    • To promote the standardized clinical application of glucose-lowering medications with demonstrated cardiovascular benefits.

    Main Methods:

    • Development of a consensus based on domestic and international guidelines.
    • Review of the latest evidence-based research on glycemic management and cardiovascular risk reduction.
    • Establishment of principles and algorithms for glucose-lowering treatment in CHD patients.

    Main Results:

    • The consensus outlines key points for type 2 diabetes screening and diagnosis in CHD patients.
    • It details comprehensive cardiovascular risk management strategies.
    • It clarifies the use of glucose-lowering medications with cardiovascular benefits, including GLP-1 RAs and SGLT-2i.

    Conclusions:

    • Standardized glycemic management is crucial for reducing cardiovascular risks in patients with CHD and type 2 diabetes.
    • Increased awareness and appropriate prescription of novel glucose-lowering agents are necessary.
    • This consensus provides a framework for optimizing cardiovascular risk reduction in this patient population.

    More Related Videos

    Improving IV Insulin Administration in a Community Hospital12:08

    Improving IV Insulin Administration in a Community Hospital

    Published on: June 11, 2012

    18.8K
    A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

    A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

    Published on: February 28, 2013

    25.7K

    Related Concept Videos

    Diabetes: Management and Pharmacotherapy01:15

    Diabetes: Management and Pharmacotherapy

    The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
    Insulin remains the cornerstone of treatment for most patients with type 1 and many...
    245
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    2.3K
    Diabetes Mellitus: Overview and Type I Subtype01:22

    Diabetes Mellitus: Overview and Type I Subtype

    Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
    Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
    2.5K
    Hypoglycemia and Glucagon01:15

    Hypoglycemia and Glucagon

    Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
    218
    Carbohydrate Metabolism01:36

    Carbohydrate Metabolism

    Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
    Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
    10.9K
    Diabetes: Symptoms, Diagnosis, and Complications01:15

    Diabetes: Symptoms, Diagnosis, and Complications

    For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
    520